Clinical Trial Update: Molecular Testing to Direct Extent of Initial Thyroid Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating molecular testing to guide the extent of initial thyroid surgery for thyroid cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: University of Pittsburgh | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED